| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | US20080096049 capable of switching between the two states in response to at least actinic radiation; thermally reversible |
| 04/23/2008 | EP1914233A1 Peripherally-selective inhibitors of dopamine-b-hydroxylase and method of their preparation |
| 04/23/2008 | EP1914230A1 Wortmannin analogs and methods of using same |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | CN100383136C Extraction method of soybean isoflavone from yellow slurry |
| 04/23/2008 | CN100383135C Refining method of ginkgo flavone |
| 04/22/2008 | US7361781 Reacting ketoisophorone with an acylating agent in the presence of methane trisulfonic acid |
| 04/22/2008 | US7361774 therapeutic agent or prophylactic agent for a disease requiring neuronal protection, suppression for nitrogen monoxide (NO) production, inhibition for aldose reductase or suppression for interleukin production, foodstuff or feed; 1-(5,6,7,8,8a,10a-hexahydro-1,7-dihydroxy-8,8,10a-trimethyl-9H-xanthen-4-yl |
| 04/17/2008 | WO2008044246A2 A process for the preparation of warfarin sodium |
| 04/17/2008 | US20080091037 Phase change ink formulations, colorant formulations, and methods of forming colorants |
| 04/17/2008 | US20080091036 Absorbs light from the visible wavelength range and is soluble in a phase change ink; new colorants with substantial hydrophobic character |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/16/2008 | EP1911761A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof |
| 04/16/2008 | EP1911757A2 Method of preparation of 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes and thiochromanes as dopamine-beta-hydroxylase inhibitors |
| 04/16/2008 | EP1910326A1 Antitumoral compounds |
| 04/16/2008 | CN101161648A Method for removing residual minim chloroform from tea polyphenol |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381436C Flavonoid compound and process for producing the same |
| 04/16/2008 | CN100381435C Extractive of general flavone from blackberry lily, preparation method and application in preparing medication |
| 04/16/2008 | CN100381434C Manufacturing method of traditional Chinese medicine formulation containing emblic leafflower fruit extract possessing anticancer, antibiotic actions |
| 04/16/2008 | CN100381433C Method for preventing oxidation of ginkgo leaf extractive |
| 04/16/2008 | CN100381431C Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 04/15/2008 | US7358383 Polyphenol proteasome inhibitors, synthesis, and methods of use |
| 04/15/2008 | US7358377 Schweinfurthin analogues |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358274 Methods for treating or preventing cancer using Benzopyranone Compounds |
| 04/15/2008 | US7358245 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 04/15/2008 | CA2343310C Polymerizable polyalkoxylated naphthopyrans |
| 04/10/2008 | WO2008040528A2 Process for preparing nebivolol |
| 04/10/2008 | WO2008040236A1 Flavones derivatives, preparation methods and uses thereof |
| 04/10/2008 | WO2008014497A3 Aldh-2 inhibitors in the treatment of addiction |
| 04/10/2008 | WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 04/10/2008 | US20080085328 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof |
| 04/10/2008 | US20080085263 Liquid Depot Formulations |
| 04/10/2008 | CA2663339A1 Process for preparing nebivolol |
| 04/09/2008 | EP1908760A1 Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
| 04/09/2008 | EP1908759A2 3,4-dihydro-3-amino-2H-1-benzopyrane and -benzothiopyrane derivatives as dopamine-beta-hydroxylase Inhibitors and methods of their preparation |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | CN101160301A Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| 04/09/2008 | CN101160300A Process for the manufacture of hydroxylated isoflavones |
| 04/09/2008 | CN101160299A Method for converting aloeresin a to aloesin |
| 04/09/2008 | CN101160160A A process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 04/09/2008 | CN101157733A Method for abstracting dihydroquercetin and arabinogalactan from larch and processing residual thereof |
| 04/09/2008 | CN101157709A Method for extracting sweet potato polyphenol from sweet potatoes |
| 04/09/2008 | CN100379732C Method for removing caffeine from theapolyphenol coarse extract |
| 04/08/2008 | US7354951 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 04/08/2008 | US7354936 2-phenylpyran-4-one derivatives |
| 04/08/2008 | US7354931 Treating obstructive airway disorders using nontoxic drug |
| 04/03/2008 | WO2006099914A8 Method for producing naringenin derivatives from xanthohumol |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/02/2008 | EP1809119B1 Consumable composition with antioxidants |
| 04/02/2008 | EP1476472B1 Novel methylated cyclodextrin complexes |
| 04/02/2008 | CN101153035A Method for extracting vitamin E from vegetable oil deodorization distillate |
| 04/02/2008 | CN101153034A Method for abstracting active ingredient of Isorhamnetin in folium ginkgo with ultrasound wave |
| 04/02/2008 | CN101153033A Method for abstracting active ingredient of kaempferol in folium ginkgo with ultrasound wave |
| 04/02/2008 | CN101153032A Method for abstracting active ingredient of meletin in folium ginkgo with ultrasound wave |
| 04/02/2008 | CN101153031A Method for extracting proanthocyanidins |
| 04/02/2008 | CN101153001A Desmosdumotin D, synthesis of derivant thereof and application of the same in against AIDS virus |
| 04/02/2008 | CN101152355A Application of ampelopsis extract in preparing medicament for treating hypertension |
| 04/02/2008 | CN100378105C Pyran isoflavone molluscacide synthesizing method |
| 04/02/2008 | CN100378089C Process for extracting total flavone from stem and leaf of scutellaria |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 04/01/2008 | US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 03/27/2008 | US20080076816 Non-Covalent Complexes Comprising Carbon Nanotubes |
| 03/27/2008 | US20080076778 PARP (poly-ADP ribose polymerase); drug screening; computer networks |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/26/2008 | EP1901738A1 Wortmannin analogs and methods of using same in combination with chemotherapeutic agents |
| 03/26/2008 | EP1140042B1 Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites |
| 03/26/2008 | CN101148444A Flavone derivative, preparation method and application |
| 03/26/2008 | CN101148443A Medicine for treating and preventing oral disease |
| 03/26/2008 | CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 03/26/2008 | CN100376244C Use of non-steroidal sulphamate compound in the preparation of medicine for treating tumor |
| 03/20/2008 | WO2008032702A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same |
| 03/20/2008 | WO2008005572A3 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof |
| 03/20/2008 | US20080071097 electrooptic display; liquid crystals |
| 03/20/2008 | US20080071095 Modulators of ATP-Binding Cassette Transporters |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070886 Anti-cancer combinations |
| 03/20/2008 | US20080070849 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
| 03/20/2008 | US20080070848 Anti-cancer combinations |
| 03/20/2008 | US20080070847 Administering 5,6-dimethylxanthenone-4-acetic acid and and administering a compound selected from platinum compounds, vinca alkaloids, alkylating agents, anthracyclines, topoisomerase I inhibitors, antimetabolites and topoisomerase II inhibitors for therapy of cancer |
| 03/20/2008 | US20080070261 Cyclohexanedione linked to a label, an anti-tumor agent, antigen, porphyrin, isotope, or a fluorophor; identifying cysteine sulfenic acids in proteins, monitoring oxidative damage in proteins and cells |
| 03/19/2008 | EP1899316A1 Benzopyranone compounds for treating cancer |
| 03/19/2008 | CN101146763A Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 03/19/2008 | CN101146528A Pharmaceutical composition comprising hydroxylated nebivolol |
| 03/19/2008 | CN101143861A B ring 4'-single substituted flavone compounds, preparation method and use |
| 03/18/2008 | US7345090 Galenical formulation |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345037 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 03/18/2008 | US7344701 For conjugation with biomolecules, drugs, and toxins |
| 03/13/2008 | WO2008031004A2 Binding of proanthocyanidins with bacteria and bacterial components |
| 03/13/2008 | WO2008030226A1 3h-naphth0 [2, 1-b] pyrans as photochromic dichroic dyes and optical article containing them |
| 03/13/2008 | WO2008029511A1 Insulin sensitivity improving agent |